BEACON introduced another promising multiple Tyrosine kinase inhibitor, Cabozanitib, under the brand name of Cabozanix for global market.

Cabozanitibis an anticancer drug for:

  • Renal Cell Carcinoma
  • Metastatic Thyroid Cancer

Cabozanix is an oral Capsule  preparation which is available in the strengths of 20 mg &80mg. Each pack Cabozanix 20 contains 90 capsules and Cabozanix 80 contains30 capsules per HDPE pot. This product is only for export.